Literature DB >> 22753433

Should Jehovah's Witness patients be listed for heart transplantation?

Elsayed Elmistekawy1, Thierry G Mesana, Marc Ruel.   

Abstract

This best evidence topic in Cardiac Surgery was written according to a structured protocol. The question addressed was: for [Jehovah's Witness patients with end-stage heart failure] can these patients undergo a [heart transplantation] without an increased rate of mortality. Altogether, 133 papers were found using the reported search strategy. Of those, 29 papers represented the best evidence to answer the clinical question. Five papers focusing on patients of the Jehovah's Witness (JW) faith who had end-stage heart failure were published. Successful heart transplantation was performed in a total of seven patients without mortality, re-exploration or blood transfusion. One patient had left ventricular reduction surgery twice and another patient had bypass surgery several years after transplantation. Other successful organ transplantations were also reported, including lung, liver, kidney and pancreas in both adult and paediatric patients of the JW faith, with comparable mortality and morbidity to non-JW patients. A publication bias is likely; nevertheless, we conclude that although there are no large studies directly focused on heart transplantation in JW patients, a multidisciplinary team approach to such surgery can make it technically feasible and without an increased mortality risk in suitable candidates. Therefore, such patients may be considered for heart transplantation under selected and favourable circumstances.

Entities:  

Mesh:

Year:  2012        PMID: 22753433      PMCID: PMC3445340          DOI: 10.1093/icvts/ivs157

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  25 in total

1.  Lung transplantation in a Jehovah's Witness.

Authors:  J V Conte; J B Orens
Journal:  J Heart Lung Transplant       Date:  1999-08       Impact factor: 10.247

2.  Cardiac transplantation in a Jehovah's witness.

Authors:  D E Lammermeier; J M Duncan; R C Kuykendall; M P Macris; O H Frazier
Journal:  Tex Heart Inst J       Date:  1988

3.  Posttransplant off-pump coronary bypass and laser revascularization in a Jehovah's Witness.

Authors:  Igor D Gregoric; Michael T Nolen; Jus Ksela; Linda B Chandler; Gregory N Messner; Roberto D Cervera; Frank W Smart; Reynolds M Delgado; O H Frazier
Journal:  Tex Heart Inst J       Date:  2005

4.  To do or not to do living donor hepatectomy in Jehovah's Witnesses: single institution experience of the first 13 resections.

Authors:  Nicolas Jabbour; Singh Gagandeep; Katrina A Bramstedt; Megan Brenner; Rodrigo Mateo; Rick Selby; Yuri Genyk
Journal:  Am J Transplant       Date:  2005-05       Impact factor: 8.086

Review 5.  Clinical strategies in the medical care of Jehovah's Witnesses.

Authors:  Paul A Remmers; Alice J Speer
Journal:  Am J Med       Date:  2006-12       Impact factor: 4.965

6.  Towards evidence-based medicine in cardiothoracic surgery: best BETS.

Authors:  Joel Dunning; Brian Prendergast; Kevin Mackway-Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

7.  Cardiovascular surgery in Jehovah's Witnesses. Report of 542 operations without blood transfusion.

Authors:  D A Ott; D A Cooley
Journal:  JAMA       Date:  1977-09-19       Impact factor: 56.272

8.  Repeat cardiac surgery in a Jehovah's Witness patient with thrombocytopenia.

Authors:  Elsayed Elmistekawy; Harry Lapierre; Michael Bourke; Carole Dennie; Marino Labinaz; Marc Ruel
Journal:  Can J Cardiol       Date:  2011-10-08       Impact factor: 5.223

9.  Left ventricular reduction in a Jehovah's Witness.

Authors:  D M McMullan; E A Beyer; I Gregoric; B Radovancevic; O H Frazier
Journal:  Ann Thorac Surg       Date:  2000-09       Impact factor: 4.330

10.  Live donor liver transplantation without blood products: strategies developed for Jehovah's Witnesses offer broad application.

Authors:  Nicolas Jabbour; Singh Gagandeep; Rodrigo Mateo; Linda Sher; Earl Strum; John Donovan; Jeffrey Kahn; Christian G Peyre; Randy Henderson; Tse-Ling Fong; Rick Selby; Yuri Genyk
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.